Mainz Biomed Stock (NASDAQ:QUCY)

Financials Chart

Previous Close

$1.73

52W Range

$0.30 - $4.88

50D Avg

$0.74

200D Avg

$0.74

Market Cap

$26.53M

Avg Vol (3M)

$909.82K

Beta

2.23

Div Yield

-

QUCY Company Profile

Mainz Biomed N.V. is a specialized enterprise in the field of molecular genetics, primarily focused on cancer diagnostics. The company's core mission involves developing and producing market-ready molecular genetic diagnostic solutions specifically engineered for life-threatening medical conditions. Beyond creation, it actively engages in the global commercialization of its product portfolio, reaching markets across Europe, the United States, and other international territories. This firm was established on March 8, 2021, and maintains its headquarters in Mainz, Germany.

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

DE

Employees

26

IPO Date

Nov 05, 2021

Website

QUCY Performance

QUCY Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$893.99K	$895.48K	$529.88K
Operating Income	$-18.70M	$-26.64M	$-26.44M
Net Income	$-21.65M	$-26.30M	$-26.39M
EBITDA	$-19.56M	$-24.87M	$-25.72M
Basic EPS	$-22.36	$-64.76	$-74.55
Diluted EPS	$-22.36	$-64.76	$-74.55

Fiscal year ends in Dec 24 | Currency in USD